Molecular subtypes of systemic sclerosis in association with anti-centromere antibodies and digital ulcers

Genes and Immunity

Volumn 10, Issue 3, 2009, Pages 210-218

  Bos, C L ^a   van Baarsen, L G M ^a   Timmer, T C G ^a   Overbeek, M J ^a   Basoski, N M ^a   Rustenburg, F ^a   Baggen, J M C ^a   Thiesen, H J ^b   Dijkmans, B A C ^a,c   van der Pouw Kraan, T C T M ^a   Voskuyl, A E ^a   Verweij, C L ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF ROSTOCK   (Germany)

^c JAN VAN BREEMEN INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CENTROMERE ANTIBODY; INTERFERON;

ADULT; AGED; ARTICLE; CELL CYCLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIGITAL ULCER; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC DIFFERENCE; GENETIC IDENTIFICATION; HUMAN; IMMUNE RESPONSE; MALE; MICROARRAY ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; SIGNAL TRANSDUCTION; SYSTEMIC SCLEROSIS; ULCER;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINUCLEAR; CENTROMERE; COHORT STUDIES; DOWN-REGULATION; FEMALE; FINGERS; GENE EXPRESSION PROFILING; HUMANS; INTERFERON TYPE I; MALE; MIDDLE AGED; SCLERODERMA, SYSTEMIC; SKIN ULCER; UP-REGULATION;

EID: 67349269613     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2008.98     Document Type: Article

References (31)

1. Derk CT, Jimenez SA. Systemic sclerosis: Current views of its pathogenesis. Autoimmun Rev 2003; 2: 181-191.
2. Denton CP, Black CM. Targeted therapy comes of age in scleroderma. Trends Immunol 2005; 26: 596-602.
3. Harris ML, Rosen A. Autoimmunity in scleroderma: The origin, pathogenetic role, and clinical significance of autoantibodies. Curr Opin Rheumatol 2003; 15: 778-784.
4. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001; 98: 5116-5121.
5. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998; 95: 14863-14868.
6. Tan FK, Zhou X, Mayes MD, Gourh P, Guo X, Marcum C et al. Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients. Rheumatology (Oxford) 2006; 45: 694-702.
7. York MR, Nagai T, Mangini AJ, Lemaire R, van Seventer JM, Lafyatis R. A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists. Arthritis Rheum 2007; 56: 1010-1020.
8. Duan H, Fleming J, Pritchard DK, Amon LM, Xue J, Arnett HA et al. Combined analysis of monocyte and lymphocyte messenger RNA expression with serum protein profiles in patients with scleroderma. Arthritis Rheum 2008; 58: 1465-1474.
9. Der SD, Zhou A, Williams BR, Silverman RH. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc Natl Acad Sci USA 1998; 95: 15623-15628.
10. Baechler EC, Batliwalla FM, Karypis G, Gaffney PM, Ortmann WA, Espe KJ et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci USA 2003; 100: 2610-2615.
11. Bennett L, Palucka AK, Arce E, Cantrell V, Borvak J, Banchereau J et al. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 2003; 197: 711-723.
12. Han GM, Chen SL, Shen N, Ye S, Bao CD, Gu YY. Analysis of gene expression profiles in human systemic lupus erythematosus using oligonucleotide microarray. Genes Immun 2003; 4: 177-186.
13. Kirou KA, Lee C, George S, Louca K, Peterson MG, Crow MK. Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease. Arthritis Rheum 2005; 52: 1491-1503.
14. van der Pouw Kraan TC, Wijbrandts CA, van Baarsen LG, Voskuyl AE, Rustenburg F, Baggen JM et al. Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: Assignment of a type I interferon signature in a subpopulation of patients. Ann Rheum Dis 2007; 66: 1008-1014.
15. Baechler EC, Bauer JW, Slattery CA, Ortmann WA, Espe KJ, Novitzke J et al. An interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activity. Mol Med 2007; 13: 59-68.
16. van Baarsen LG, van der Pouw Kraan TC, Kragt JJ, Baggen JM, Rustenburg F, Hooper T et al. A subtype of multiple sclerosis defined by an activated immune defense program. Genes Immun 2006; 7: 522-531.
17. Bave U, Nordmark G, Lovgren T, Ronnelid J, Cajander S, Eloranta ML et al. Activation of the type I interferon system in primary Sjogren's syndrome: A possible etiopathogenic mechanism. Arthritis Rheum 2005; 52: 1185-1195.
18. van Baarsen LG, Vosslamber S, Tijssen M, Baggen JM, van der Voort LV, Killestein J et al. Pharmacogenomics of interferon-beta therapy in multiple sclerosis: Baseline IFN signature determines pharmacological differences between patients. PLoS ONE 2008; 3: E1927.
19. Indraccolo S, Pfeffer U, Minuzzo S, Esposito G, Roni V, Mandruzzato S et al. Identification of genes selectively regulated by IFNs in endothelial cells. J Immunol 2007; 178: 1122-1135.
20. Marshak-Rothstein A. Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol 2006; 6: 823-835.
21. Hamamdzic D, Kasman LM, LeRoy EC. The role of infectious agents in the pathogenesis of systemic sclerosis. Curr Opin Rheumatol 2002; 14: 694-698.
22. Ronnblom L, Eloranta ML, Alm GV. The type I interferon system in systemic lupus erythematosus. Arthritis Rheum 2006; 54: 408-420.
23. Chen ZY, Virella G, Tung HE, Ainsworth SK, Silver RM, Wang AC et al. Immune complexes and antinuclear, antinucleolar, and anticentromere antibodies in scleroderma. J Am Acad Dermatol 1984; 11: 461-467.
24. Hua J, Kirou K, Lee C, Crow MK. Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies. Arthritis Rheum 2006; 54: 1906-1916.
25. Christensen SR, Shupe J, Nickerson K, Kashgarian M, Flavell RA, Shlomchik MJ. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 2006; 25: 417-428.
26. Preliminary criteria for the Classification of Systemic Sclerosis (Scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980; 23: 581-590.
27. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger Jr TA et al. Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis. J Rheumatol 1988; 15: 202-205.
28. Perou CM, Jeffrey SS, van de RM, Rees CA, Eisen MB, Ross DT et al. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc Natl Acad Sci USA 1999; 96: 9212-9217.
29. Demeter J, Beauheim C, Gollub J, Hernandez-Boussard T, Jin H, Maier D et al. The Stanford Microarray Database: Implementation of new analysis tools and open source release of software. Nucleic Acids Res 2007; 35: D766-D770.
30. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001; 98: 5116-5121.
31. Mi H, Lazareva-Ulitsky B, Loo R, Kejariwal A, Vandergriff J, Rabkin S et al. The PANTHER database of protein families, subfamilies, functions and pathways. Nucleic Acids Res 2005; 33: D284-D288.